Nanjing Vazyme Biotech Co Ltd
688105
Company Profile
Business description
Nanjing Vazyme Biotech Co Ltd is engaged in conducting technological research and product development focusing on functional proteins such as enzymes, antigens, and antibodies, as well as high molecular weight organic materials.
Contact
Kechuang Road
Building D2, Hongfeng Science and Technology Park
Economic and Technological Development Zone
Jiangsu Province
Nanjing210033
CHNT: +86 2585771179
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
3,002
Stocks News & Analysis
stocks
7 undervalued US stocks that crushed earnings
Arista and GE Vernova remain among the cheapest Morningstar-covered stocks after strong earnings beats.
stocks
Undervalued ASX share hitting on all cylinders
Strong performance across all segments in latest earnings release.
stocks
Investor Playbook: Can your portfolio handle what’s next?
Testing portfolio resilience in an uncertain market.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,194.70 | 9.80 | -0.11% |
| CAC 40 | 8,368.91 | 7.55 | 0.09% |
| DAX 40 | 26,749.95 | 21.93 | -0.08% |
| Dow JONES (US) | 52,347.55 | 50.46 | 0.10% |
| FTSE 100 | 10,902.56 | 39.47 | 0.36% |
| HKSE | 23,802.30 | 164.70 | 0.70% |
| NASDAQ | 25,136.27 | 229.82 | -0.91% |
| Nikkei 225 | 60,176.85 | 965.50 | -1.58% |
| NZX 50 Index | 14,242.13 | 68.45 | 0.48% |
| S&P 500 | 7,561.67 | 30.73 | -0.40% |
| S&P/ASX 200 | 9,073.70 | 8.50 | -0.09% |
| SSE Composite Index | 3,601.05 | 33.30 | -0.92% |